webinar register page

Webinar banner
UCD Smurfit School Laurence Crowley Lecture Series 1pm - 2pm Nov 4 2020
The struggle for transparency in times of COVID-19:
Challenges for pharmaceutical advocacy in Europe

Lecture delivered by Yannis Natsis

Policy Manager for Universal Access and Affordable Medicines, European Public Health Alliance (EPHA)
Management Board member, European Medicines Agency (EMA)

Given the scale of the COVID-19 pandemic and the unprecedented mobilisation of governments' resources, one could have imagined that the business as usual way of dealing with the pharmaceutical industries would not have been blindly followed.

The onset of the public health emergency offered a glimmer of hope for permanent positive change in the pharmaceutical business model, rather than confrontation with the sector. Transparency seemed to be one of the most promising areas, especially given the positive signs to this end, in recent years in Europe.

Almost a year into the COVID-19 pandemic, these hopes have been somewhat dashed. We are now moving backwards.

As policy-makers turn to the pharmaceutical manufacturers for help, a "no questions asked" approach seems to be prevailing, shrouded in confidential deals with companies.

Governments appear to be unwilling to use their leverage and are missing their chance to reform the pharmaceutical sector. With this lecture, we look at the watershed moments, the winners, losers and the prospects in the access to pharmaceutical policy discussions in Brussels and beyond.

Nov 4, 2020 01:00 PM in Dublin

* Required information
Loading

By registering, I agree to the Privacy Statement and Terms of Service.

Register

Speakers

Yannis Natsis
Policy Manager for Universal Access and Affordable Medicines, European Public Health Alliance (EPHA) @European Medicines Agency (EMA), Management Board member
Yannis currently leads the advocacy for better and affordable medicines at the European Public Health Alliance (EPHA), the leading public health stakeholder in Brussels. Before joining EPHA in January 2016, he worked at the European Parliament, the Greek Ministry of Foreign Affairs, the UN and the private sector in Brussels and Athens. Between 2013-2015, Yannis was Advocacy Advisor for the TransAtlantic Consumer Dialogue (TACD) focusing on access to medicines. Between 2006-2010, he was an investigative reporter for Greece’s award-winning TV news programme “Fakeli” and a contributor to the Greek daily “Kathimerini”.
Professor Jan Rosier
Professor of Business of Biotechnology @University College Dublin, School of Biomolecular and Biomedical Science
Professor Rosier holds both a Doctorate in Pharmaceutical Sciences (Ghent University, Belgium) and a Doctorate in Management (Cranfield School of Management, UK). He was a Fulbright Scholar at Harvard University and was awarded a NATO research fellowship for research at MIT, Cambridge. He was vice president pharmaceutical drug development at Johnson & and was awarded the Johnson & Johnson Leadership Award for outstanding and exceptional contribution to the development of PREZISTA® and INTELENCE® for the treatment of AIDS.
Professor Gerardine Doyle
Associate Dean and Director UCD Smurfit School @UCD Smurfit School
Professor of Accounting and Taxation, Gerardine is Director of the Michael Smurfit Graduate Business School and is Associate Dean of the UCD College of Business. Prior to being Director of the Smurfit School Gerardine has successfully undertaken several significant leadership roles in the School including Head of Accountancy Subject Area, Head of Teaching and Learning and Programme Director, MBA Health Services Management. Beyond the university, Gerardine has been a member of and chaired several significant committees and boards, including the Audit Committee of the Health Service Executive and the European Institute of Advanced Studies in Management.